Impact of perioperative glycaemia and glycated haemoglobin on the outcomes of the surgical treatment of diabetic foot osteomyelitis

Javier Aragón-Sánchez; José Luis Lázaro-Martínez

doi:10.1016/j.diabres.2011.09.009

Impact of perioperative glycaemia and glycated haemoglobin on the outcomes of the surgical treatment of diabetic foot osteomyelitis

Diabetes Res Clin Pract. 2011 Dec;94(3):e83-5. doi: 10.1016/j.diabres.2011.09.009. Epub 2011 Sep 28.

Authors

Javier Aragón-Sánchez¹, José Luis Lázaro-Martínez

Affiliation

¹ Diabetic Foot Unit, La Paloma Hospital, Las Palmas de Gran Canaria, Spain. javiaragon@telefonica.net

PMID: 21955961
DOI: 10.1016/j.diabres.2011.09.009

Abstract

Perioperative glycaemic control during admission was a predictive factor of amputation in a prospective cohort of 81 patients with diabetes who underwent surgical treatment for osteomyelitis. Glycaemic control before admission, as determined by glycosylated haemoglobin, did not have any influence on the outcomes.

MeSH terms

Aged
Blood Glucose / metabolism*
Diabetes Complications / blood
Diabetes Complications / etiology
Diabetes Mellitus / physiopathology*
Diabetic Foot / etiology
Diabetic Foot / surgery*
Glycated Hemoglobin / metabolism*
Glycemic Index
Humans
Osteomyelitis / etiology
Osteomyelitis / surgery*
Prospective Studies
Treatment Outcome

Substances

Blood Glucose
Glycated Hemoglobin A